Author: Janine Anthes

Prediction independent of traditional risk factors such as MetS, glucose, HbA1c in general population

Specialty and larger practice size are correlates of telemedicine use

Risk reduced with trastuzumab emtansine in those with residual invasive dz at sx after neoadjuvant chemo

Median progression-free survival improved with A+CHP vs CHOP; similar incidence of adverse events

Risk for patients in rivaroxaban group reduced during the on-treatment period

Significant association for men, with positive but not statistically significant link seen for women

Findings show delaying chemo over 30 days postsurgery lowers triple-negative breast cancer survival

Both shorter and longer estimated total sleep durations linked to increased risk

Subsequent risk increased with infections requiring hospitalization, treatment with anti-infective agents

Alemtuzumab label will be updated to include the risk for stroke and arterial dissection

Participants report no difficulty understanding directions for self-collection, willing to use in future

Link significantly increased with increased subjective workload

Phase II clinical trial results, mouse model study show no link between serum urate, changes in BP

Exercise intervention linked to reversal of functional declines associated with hospitalization

Increase especially great among women, who were less likely to receive guideline-based treatment

Ottawa COPD Risk Scale is valid for predicting short-term serious outcomes for patients in the ED

Although still low, use increased rapidly from 2010 to 2017

Method evaluating cells collected from urine shows 94 percent diagnostic accuracy

Highest rates of active disease seen for children aged 0 to 17 years and older adults aged 75 to 99

Estimated coverage with MCV1 up from 72 to 85 percent globally; measles deaths dropped 80 percent